Table 1.

Summary of Publications Reporting the Effectiveness and Safety of Influenza Vaccines

Outcomea	Publications per Vaccine Type, No.a
	Inactivated	Live	Both	Not Specified
Influenzab (7 publications)	1 (Sugaya 1994 [A26])	2 (Miyazaki 1993 [A12] and Tanaka 1993 [A20])	1 (Fleming 2006 [A6])	3 (McLean 2015 [A31], Ohmit 2014 [A32], and Otero 2009 [A33])
Asthma exacerbationb (7 publications)	4 (Bueving 2004 [A3], Abadoglu 2004 [A21], Sugaya 1994 [A26], and Jaiwong 2015 [A28])	0	0	3 (Gharagozlou 2006 [A7], Kramarz 2001 [A29], and Watanabe 2005 [A35])
Hospitalization (6 publications)	4 (Bell 1978 [A2], Abadoglu 2004 [A21], Sugaya 1994 [A26], and Jaiwong 2015 [A28])	0	0	2 (Gharagozlou 2006 [A7] and Christy 2004 [A27])
Consultations (2 publications)	0	0	1 (Fleming 2006 [A6])	1 (Christy 2004 [A27])
Emergency visits (3 publications)	1 (Jaiwong 2015 [A28])	0	0	2 (Gharagozlou 2006 [A7] and Christy 2004 [A27])
Respiratory illness (8 publications)	5 (Bueving 2004 [A3], Abadoglu 2004 [A21], Sugaya 1994 [A26], Jaiwong 2015 [A28], and Smits 2002 [A34])	2 (Miyazaki 1993 [A12] and Tanaka 1993 [A20])	0	1 (Jaiwong 2015 [A28])
Asthma medication (2 publications)	1 (Jaiwong 2015 [A28])	0	0	1 (Gharagozlou 2006 [A7])
Pulmonary function (1 publication)	1 (Abadoglu 2004 [A21])	0	0	0
School/work absence (1 publication)	0	0	1 (Fleming 2006 [A6])	0
Safety (24 publications)	17 (Bell 1978 [A2], Bueving 2004 [A4], Castro 2001 [A5], Govaert 1993 [A8], Hahn 1980 [A9], Kmiecik 2007 [A10], Miller 2003 [A11], Nicholson 1998 [A13], Ortwein 1987 [A14], Pedroza 2009 [A15], Reid 1998 [A17], Sener 1999 [A18], Stenius 1986 [A19], Campbell 1984 [A22], Chiu 2003 [A23], Kava 1987 [A24], and Kim 2003 [A25])	4 (Atmar 1990 [A1], Miyazaki 1993 [A12], Redding 2002 [A16], and Tanaka 1993 [A20])	1 (Fleming 2006 [A6])	2 (Gharagoszlou 2006 [A7] and Kramarz 2000 [A30])

^aSee Supplementary Appendix II for details.

^bPrimary outcome.